Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin on circadian rest-activity rhythms in bipolar disorder
IRCT20200913048705N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in bipolar disorder (BD), sponsored by Zahedan University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
melatonin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20200913048705N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200913048705N1.